AKIN GUMP STRAUSS HAUER & FELD

Lobbying for UCB, INC. · Biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Georgia · House · Senate · $80,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Trade (domestic/foreign)

Issues related to global biopharmaceutical supply chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem